N/A(healthy adults)
Conditions
Interventions
Oral ingestion of the test food for 24 days
Oral ingestion of the placebo food for 24 days
Sponsors
MORINAGA & CO., LTD.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Japanese individuals aged 30-69 years. 2)Individuals who are not suffered from a chronic malady including skin disease. 3)Individuals who are anxious about skin dryness. 4)Individuals whose written informed consent has been obtained. 5)Individulals who can visit an inspection facility and be inspected in designated days. 6)Individuals judged appropriate for the study by the principal.
Exclusion criteria
Exclusion criteria: 1)Individuals using medical products. 2)Individuals with skin disease symptoms such as atopic dermatitis. 3)Individuals with strange skin conditions at measurement points. 4)Individuals who used or applied a drug for treatment of disease in the past 1 month. 5)Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung and blood disease. 6)Individuals who contract or have a history of serious gastrointestinal disease. 7)Individuals with serious anemia. 8)Individuals with food allergy. 9)Females who are or are possibly pregnant, or are lactating. 10)Individuals who have an addiction to alcohol or a mental illness. 11)Individuals who are a smoker. 12)Individuals whose life style will change during the test period. 13)Individuals with probable seasonal allergy, such as pollinosis, during the test period. 14)Individuals who will get sunburned during the test period. 15)Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements that have the function of maintaining and improving skin moisture in the past 3 months or will ingest those foods during the test period. 16)Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months. 17)Individuals who conducted hormone replacement therapy in the past 6 months or have a history of conducting hormone replacement therapy. 18)Individuals who have received a cosmetic medicine in the past 6 months. 19)Individuals who were hospitalized and received treatment in the past 6 months. 20)Individuals who participated in other clinical studies in the past 3 months. 21)Individuals judged inappropriate for the study by the principal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indexes for skin conditions (0, 24 days after ingestion) | — |
Countries
Japan
Contacts
Public ContactSadao Mori
MORINAGA & CO., LTD. Health Science and Research Center, R&D institute
Outcome results
None listed